Skip to Content

Notice

Notice of Commission Determination to Conduct a Portion of the Hearing In Camera

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

U.S. International Trade Commission.

ACTION:

Closure of a portion of a Commission hearing.

SUMMARY:

Upon request of Chinese producer, Hubei Xingfa Chemical Group Company, Ltd. (Xingfa), the Commission has determined to conduct a portion of its hearing in the above-captioned investigation scheduled for January 24, 2008, in camera. See Commission rules 207.24(d), 201.13(m) and 201.36(b)(4) (19 CFR 207.24(d), 201.13(m) and 201.36(b)(4)). The remainder of the hearing will be open to the public. The Commission has determined that the seven-day advance notice of the change to a meeting was not possible. See Commission rule 201.35(a), (c)(1) (19 CFR 201.35(a), (c)(1)).

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Robin L. Turner, Esq., Office of the General Counsel, United States International Trade Commission, 202-205-3103. Hearing-impaired individuals are advised that information on this matter may be obtained by contacting the Commission's TDD terminal on 202-205-3105.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

The Commission believes that Xingfa has justified the need for a closed session. In this review, significant data for the domestic and foreign producers and subject imports are business proprietary. Xingfa seeks a closed session in order to fully address the issues before the Commission without referring to business proprietary information. In making this decision, the Commission nevertheless reaffirms its belief that Start Printed Page 5212whenever possible its business should be conducted in public.

The hearing will include the usual public presentations by petitioners and by respondents, with questions from the Commission. In addition, the hearing will include a 10-minute in camera session for a confidential presentation by Chinese Respondent, Xingfa. This session will be followed by questions from the Commission relating to the BPI and a 10-minute in camera rebuttal presentation by petitioners, if needed. Following the in camera session, the Commission will reopen the hearing to the public for the public rebuttal/closing statements. During the in camera session the room will be cleared of all persons except those who have been granted access to BPI under a Commission administrative protective order (APO) and are included on the Commission's APO service list in this investigation. See 19 CFR 201.35(b). The time for the parties' presentations and rebuttals in the in camera session will be taken from their respective overall time allotments for the hearing. All persons planning to attend the in camera portions of the hearing should be prepared to present proper identification.

Start Authority

Authority: The General Counsel has certified, pursuant to Commission Rule 201.39 (19 CFR 201.39) that a portion of the Commission's hearing in Sodium Hexametaphosphate from China, Inv. No. 731-TA-1110 (Final), may be closed to the public to prevent the disclosure of BPI.

End Authority Start Signature

Issued: January 22, 2008.

By order of the Commission.

Marilyn R. Abbott,

Secretary to the Commission.

End Signature End Supplemental Information

[FR Doc. E8-1508 Filed 1-28-08; 8:45 am]

BILLING CODE 7020-02-P